PTC Therapeutics to Participate in Upcoming Investor Conferences

WARREN, N.J., Feb. 20, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will participate in fireside chats at the following investor conferences:

TD Cowen 45th Annual Health Care 2025 Conference  Tuesday, March 4 at 11:10 a.m. ET

Barclays 27th Annual Global Healthcare ConferenceTuesday, March 11 at 12:30 p.m. ET

The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn, and X.

For More Information:

Investors:Ellen Cavaleri+1 (615) 618-6228ecavaleri@ptcbio.com 

Media:Jeanine Clemente+1 (908) 912-9406jclemente@ptcbio.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-in-upcoming-investor-conferences-302381204.html

SOURCE PTC Therapeutics, Inc.